Haisco Pharmaceutical Group is a fully integrated, innovation-driven Chinese pharmaceutical enterprise specializing in the research, development, clinical testing, manufacturing, and commercial distribution of advanced therapeutic medicines. The corporation maintains an extensive portfolio spanning specialty injections, active pharmaceutical ingredients, oral tablets, and complex compounds across critical medical fields such as metabolic diseases, central nervous system disorders, oncology, and general anesthesia.